See more : MMTec, Inc. (MTC) Income Statement Analysis – Financial Results
Complete financial analysis of The Beauty Health Company (SKIN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Beauty Health Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Empire State Realty Trust, Inc. (ESRT) Income Statement Analysis – Financial Results
- Ellomay Capital Ltd. (ELLO) Income Statement Analysis – Financial Results
- WuXi Biologics (Cayman) Inc. (2269.HK) Income Statement Analysis – Financial Results
- Hi Gold Ocean Kmarin No.12 Ship Investment Company (172580.KS) Income Statement Analysis – Financial Results
- Sprocomm Intelligence Limited (1401.HK) Income Statement Analysis – Financial Results
The Beauty Health Company (SKIN)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.beautyhealth.com
About The Beauty Health Company
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 397.99M | 365.88M | 260.09M | 119.09M | 166.62M | 112.31M |
Cost of Revenue | 242.88M | 115.54M | 78.26M | 51.89M | 60.11M | 39.34M |
Gross Profit | 155.11M | 250.34M | 181.83M | 67.20M | 106.51M | 72.98M |
Gross Profit Ratio | 38.97% | 68.42% | 69.91% | 56.43% | 63.92% | 64.98% |
Research & Development | 10.10M | 8.44M | 8.20M | 3.41M | 4.61M | 2.40M |
General & Administrative | 131.43M | 106.10M | 98.69M | 30.65M | 26.66M | 17.77M |
Selling & Marketing | 144.50M | 160.08M | 111.58M | 50.32M | 61.77M | 42.74M |
SG&A | 275.93M | 266.18M | 210.27M | 80.97M | 88.44M | 60.51M |
Other Expenses | 0.00 | -1.65M | -51.55M | -47.00K | 535.00K | -9.00K |
Operating Expenses | 286.03M | 274.62M | 218.47M | 84.38M | 93.05M | 62.92M |
Cost & Expenses | 528.91M | 390.16M | 296.73M | 136.27M | 153.16M | 102.25M |
Interest Income | 23.17M | 9.18M | 39.00K | 21.28M | 17.09M | 0.00 |
Interest Expense | 13.65M | 13.39M | 11.78M | 21.28M | 17.09M | 10.05M |
Depreciation & Amortization | 34.68M | 22.02M | 21.14M | 14.40M | 13.74M | 11.50M |
EBITDA | -56.00M | 80.75M | -344.44M | -2.81M | 27.90M | 21.56M |
EBITDA Ratio | -14.07% | -4.58% | -33.91% | -2.37% | 16.73% | 19.19% |
Operating Income | -130.92M | -24.28M | -36.64M | -17.18M | 13.46M | 10.06M |
Operating Income Ratio | -32.89% | -6.64% | -14.09% | -14.43% | 8.08% | 8.96% |
Total Other Income/Expenses | 29.03M | 71.18M | -337.42M | -21.30M | -16.40M | -10.05M |
Income Before Tax | -101.89M | 45.03M | -377.35M | -38.48M | -2.94M | 10.00K |
Income Before Tax Ratio | -25.60% | 12.31% | -145.09% | -32.31% | -1.76% | 0.01% |
Income Tax Expense | -1.77M | 648.00K | -2.24M | -9.31M | -1.30M | 327.00K |
Net Income | -100.12M | 44.22M | -375.11M | -29.18M | -1.64M | -317.00K |
Net Income Ratio | -25.16% | 12.09% | -144.22% | -24.50% | -0.98% | -0.28% |
EPS | -0.76 | 0.30 | -3.67 | -0.85 | -0.05 | 0.00 |
EPS Diluted | -0.76 | -0.23 | -3.67 | -0.85 | -0.05 | 0.00 |
Weighted Avg Shares Out | 131.68M | 147.55M | 102.11M | 34.29M | 32.14M | 125.40M |
Weighted Avg Shares Out (Dil) | 131.68M | 148.51M | 102.11M | 34.29M | 32.14M | 125.40M |
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of The Beauty Health Company of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SKIN)
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
SKIN Investors Have Opportunity to Lead The Beauty Health Company Securities Fraud Lawsuit
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Beauty Health Company Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SKIN
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
SHAREHOLDER ALERT: Levi & Korsinsky Notifies The Beauty Health Company(SKIN) Investors of a Class Action Lawsuit and Upcoming Deadline
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
SKIN Investors Have Opportunity to Lead The Beauty Health Company Securities Fraud Lawsuit
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
Source: https://incomestatements.info
Category: Stock Reports